The Application of Nanotechnology for the Diagnosis and Treatment of Endocrine Disorders: A Review of Current Trends, Toxicology and Future Perspective

Yan Yan,Hanqing Cai,Maoguang Yang

DOI: https://doi.org/10.2147/ijn.s477835

IF: 7.033

2024-09-26

International Journal of Nanomedicine

Abstract:Yan Yan, Hanqing Cai, Maoguang Yang Department of Endocrinology, The Second Hospital of Jilin University, Changchun, 13000, People's Republic of China Correspondence: Maoguang Yang, Department of Endocrinology, The Second Hospital of Jilin University, Changchun, 13000, People's Republic of China, Email The endocrine system regulates many biological systems, and disruptions may result in disorders, such as diabetes, thyroid dysfunction, Cushing's syndrome, and obesity. The total incidence of endocrine illnesses was found to be 47.4%, excluding type 2 diabetes mellitus, with a significant frequency of newly diagnosed endocrine disorders. Nanotechnology manipulates particles at the atomic and molecular levels, opening up new paths for studying disease etiology and therapeutic alternatives. The goal of using nanomaterials in the treatment of endocrine illnesses is to create endogenous nano-biosensors that can detect even modest changes in hormone levels and react spontaneously to restore normal function. The size and surface characteristics of nanoparticles enhances the sensitivity in nano-sensors and are functionalized for targeted drug delivery. Nano-sized carriers composed of lipids, polymers, carbon, or metals have been shown to work much better than standard drug delivery methods. Nanoparticles (NPs) offer various advantages over current methods for diagnosing and treating endocrine disorders, acting as hydrogels for insulin delivery and wound healing. Incorporating selenium NPs into inorganic nanoparticles enhances their bioactivity and targeted delivery. Gold NPs show a promising precise insulin delivery. Mesoporous silica NPs maintain glycemic level effectively and lipid and polymeric NPs protect drugs from degradation in the gastrointestinal tract. Carbon nanotubes (CNTs) have become popular in thyroid surgeries. These characteristics make nanoparticles valuable for developing effective diagnostic and therapeutic systems. NP-based medicines have been thoroughly researched in order to identify the beginning point for the creation of theranostics, which may function in two ways: as imaging agents or therapeutics. The study posits that nanotechnology bridges diagnostics and therapies, potentially revolutionizing endocrine disorder treatments. This review delves into nanotechnology techniques, emphasizing their applications in diagnosing and treating diabetes mellitus. Keywords: nanomedicines, theranostics, endocrine disorders, diabetes, thyroid dysfunction The endocrine system is made up of several glands that secrete hormones that play an important role in regulating different physiological activities. These glands might exist as fully developed organs or as a smattering of tissues and cells. Endocrine malfunction may result in a variety of disorders, such as diabetes, thyroid dysfunction, Cushing's syndrome, and obesity. While there is no treatment for these conditions, modern drugs may help to monitor and maintain hormone levels as near to natural levels as feasible, hence assisting in the preservation of bodily hemostasis. 1 The overall incidence of endocrine diseases, excluding type 2 diabetes mellitus, was found to be 47.4%. Primary hypothyroidism was diagnosed in 18.1% of patients, whereas pituitary disease, Cushing syndrome, and other endocrine illnesses were found in 1.9%, 0.8%, and less than 1%, respectively. Remarkably, the study also revealed a high prevalence of newly diagnosed endocrine disorders, which were found in 16.3% of patients. 2 According to the study conducted to check the prevalence of endocrine disorders in obese patients, it has been found that about 14% of obese had hypothyroidism; other 14.6% had milder form of hypothyroidism called subclinical hypothyroidism. 3 The population of the United States is plagued by a wide variety of endocrine disorders, such as thyroiditis, diabetes, impaired insulin responsiveness, obesity, metabolic syndrome, osteoporosis, osteopenia, mild-to-moderate hypovitaminosis D, erectile dysfunction, and dyslipidemia. Some of these disorders are more prevalent in some demographics than others. 4 Findings from the recent study also describe that individuals with Down syndrome in the United States face a greater prevalence of endocrine disorders compared to individuals of the same age and sex who do not have Down Syndrome. 5 These diseases affect at least 5% of the adult population in the United States, resulting in substantial health and economic consequences. 4 Over the last decade, nanotechnology has seen significant integration into biomedical applications, such as drug delivery, disease diagnosis, and diagnostic imaging. Nanotechnology is the manipulation of atomic and molecular particles with at least one dimension ranging from 1 to 100 nanometers which are called nanoparticles.<sup -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology